<DOC>
	<DOC>NCT00204737</DOC>
	<brief_summary>The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo</brief_summary>
	<brief_title>Short Course Glucocorticoid Treatment for PTSD</brief_title>
	<detailed_description>See attached document</detailed_description>
	<mesh_term>Stress Disorders, Traumatic</mesh_term>
	<mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Must meet DSMIV criteria for PTSD w/ symptom exacerbation (CAPS score â‰¥ 50) Stable on other psychotropic meds x1 month Current or past history of bipolar, schizophrenic, or other psychotic disorder Organic mental disorder Alcohol or substance abuse in last 3 months Clinically significant hepatic or renal disease or other acute or unstable medical condition COPD, asthma, uncontrolled diabetes, rheumatologic diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>